Cardiac Implants Announces Successful Therapeutic Adjustment Procedure Using Tri-Ring™ Percutaneous Annuloplasty Device
Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring percutaneous annuloplasty device.
- Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring percutaneous annuloplasty device.
- The adjustment procedure represents the first minimally invasive percutaneous annuloplasty in the United States using a two-stage clinical approach and utilized Cardiac Implants second-generation Tri-Ring percutaneous annuloplasty device , a complete circular ring implanted from the internal jugular vein in the neck.
- We are very excited to see the potential for the performance of the Tri-Ring Annuloplasty Device, said Dr. Mark Turco, CEO, Cardiac Implants.
- The Cardiac Implants annuloplasty device allows structural heart interventionalists to percutaneously deliver a complete ring on the tricuspid valve annulus.